Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sunshine Biopharma (SBFM) Revenue: 2012-2024

Historic Revenue for Sunshine Biopharma (SBFM) over the last 11 years, with Dec 2024 value amounting to $34.9 million.

  • Sunshine Biopharma's Revenue rose 11.64% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.3 million, marking a year-over-year increase of 13.24%. This contributed to the annual value of $34.9 million for FY2024, which is 44.75% up from last year.
  • Sunshine Biopharma's Revenue amounted to $34.9 million in FY2024, which was up 44.75% from $24.1 million recorded in FY2023.
  • Over the past 5 years, Sunshine Biopharma's Revenue peaked at $34.9 million during FY2024, and registered a low of $71,410 during FY2020.
  • Its 3-year average for Revenue is $21.1 million, with a median of $24.1 million in 2023.
  • Per our database at Business Quant, Sunshine Biopharma's Revenue skyrocketed by 1,802.41% in 2022 and then tumbled by 44.75% in 2024.
  • Over the past 5 years, Sunshine Biopharma's Revenue (MRY) stood at $71,410 in 2020, then soared by 219.88% to $228,426 in 2021, then soared by 1,802.41% to $4.3 million in 2022, then surged by 454.42% to $24.1 million in 2023, then soared by 44.75% to $34.9 million in 2024.
  • Its last three reported values are $34.9 million in FY2024, $24.1 million for FY2023, and $4.3 million during FY2022.